Omeros (OMER) financial statements

Healthcare · Biotechnology · Market cap $1.2B

Net income was -$3M.

Free cash flow was -$116M.

The diluted share count rose 57% over the period (dilution).

Revenue and free cash flow

Fiscal years, $ billions.

-0.2-0.100.10.22016201720182019202020212022202320242025RevenueFree cash flow
Embed this chart

Free to use in articles and newsletters with the source line. Paste this HTML:

Income statement

Fiscal years, from Omeros's 10-K filings with the SEC.

Fiscal year2016201720182019202020212022202320242025
Revenue$42M$65M$30M$112M$74M—————
Cost of revenue$1M$1M$512,000$865,000$902,000—————
Gross profit$40M$64M$29M$111M$73M—————
Research and development$51M$56M$90M$106M$108M$119M$113M$115M$120M$81M
Selling, general and admin$44M$52M$52M$40M$49M$55M$51M$50M$47M$42M
Operating income-$54M-$44M-$112M-$146M-$157M-$174M-$163M-$165M-$167M-$123M
Interest expense$8M$11M$16M$23M$27M$20M$23M$31M$25M-$960,000
Pre-tax income-$67M-$53M-$140M-$167M-$196M-$192M-$182M-$175M-$180M-$3M
Income tax$0$0-$13M-$20M-$23M$0$0$0$2M$2M
Net income-$67M-$53M-$127M-$84M-$138M$194M$47M-$118M-$157M-$3M
EPS (diluted)-$1.65-$1.17-$2.61-$1.71-$2.41$3.12$0.76-$1.88-$2.70-$0.05
Diluted shares40M46M49M50M57M62M63M63M58M64M
Gross margin96.6%98.3%98.3%99.2%98.8%—————
Operating margin-130.4%-67.7%-375.7%-130.6%-212.6%—————
Net margin-160.4%-82.5%-424.4%-75.6%-187.0%—————

Balance sheet

Fiscal years, from Omeros's 10-K filings with the SEC.

Fiscal year2016201720182019202020212022202320242025
Cash and short-term investments$45M$84M$60M$61M$135M$157M$195M$172M$90M$172M
Receivables$12M$17M$23M$35M$4M$38M$213M$8M$8M$11M
Inventory$1M$443,000$88,000$1M$1M————$0
Total current assets$60M$108M$90M$104M$151M$248M$443M$218M$134M$216M
Property, plant and equipment$1M$2M$4M$4M$3M$2M$1M$2M$3M$2M
Total assets$67M$116M$96M$137M$181M$419M$591M$378M$277M$326M
Total current liabilities$16M$26M$37M$55M$37M$52M$136M$53M$80M$78M
Long-term debt$80M$84M————————
Total liabilities$105M$119M$196M$246M$302M$395M$505M$403M$460M$447M
Shareholders' equity-$37M-$3M-$100M-$109M-$121M$24M$86M-$25M-$183M-$121M
Net debt$77M$81M-$5M-$3M-$11M-$101M-$11M-$7M-$3M-$10M

Cash flow

Fiscal years, from Omeros's 10-K filings with the SEC.

Fiscal year2016201720182019202020212022202320242025
Operating cash flow-$52M-$36M-$104M-$60M-$100M-$110M-$86M$75M-$149M-$116M
Capital spending$126,000$350,000$567,000$334,000$283,000$277,000$113,000$426,000$165,000$65,000
Free cash flow-$52M-$37M-$104M-$60M-$100M-$110M-$87M$74M-$149M-$116M
Stock-based compensation$14M$13M$12M$14M$15M$18M$14M$12M$10M$8M
Share buybacks (net)—————$0$0-$5M-$12M$0
Net borrowing$100M$0$45M———————
Free cash flow margin-124.1%-56.4%-349.2%-54.0%-136.0%—————
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for OMER.
Open OMER in Investingly

Questions

How much free cash flow does Omeros generate?

-$116M in fiscal 2025 (operating cash flow minus capital spending).

From Omeros's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.